Construction of magnetic-targeted and NIR irradiation-controlled drug delivery platform with Fe3O4@Au@SiO2 nanospheres
Source abstract
Abstract
Near-infrared (NIR) light has great potential in biomedical applications due to its advantages of deep penetration depth and low photodamage to biological tissues. In this paper, we constructed a novel core-shell structured drug nanocarrier, Fe3O4@Au@SiO2, for the controlled delivery of etoposide (VP16), a chemotherapeutic drug for cancer patients. The novel core-shell structured drug delivery platform is composed of a mesoporous silica shell and a magnetic Fe3O4 core using Au nanoparticles (AuNPs) as the interlayer, which is characterized by atomic force microscopy (AFM), X-ray diffraction (XRD), Fourier-transform infrared (FTIR) spectroscopy, N2 adsorption/desorption isotherms and the magnetic measurements with vibrating-sample magnetometer (VSM). The synergistic effects of AuNPs, mesoporous silica and Fe3O4 make the core-shell structured nanocomposites an excellent candidate for targeted and NIR light irradiation-controlled drug delivery. For the proposed nanocarrier of VP16, the mesopores in silica can enhance the encapsulation capacity of the nanocarrier and the AuNPs can effectively convert the NIR light into heat to speed up the drug deliver; meanwhile, the incorporation of Fe3O4 with high magnetization to the drug delivery platform realize drug targeting under an applied external magnetic field.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Carbon and Quantum Dots Applications · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (49)
Show source-provided references
1. Nanocarriers as an emerging platform for cancer therapy10.1038/nnano.2007.387 ↗
2. Synthesis of CaCO3 nanobelts for drug delivery in cancer therapy10.1186/s11671-015-0948-6 ↗
3. Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system10.3109/10717544.2016.1141258 ↗
4. Novel Fe3O4@ZnO@mSiO2 nanocarrier for targeted drug delivery and controllable release with microwave irradiation10.1021/jp502820r ↗
5. Multifunctional Fe3O4@WO3@mSiO2-APTES nanocarrier for targeted drug delivery and controllable release with microwave irradiation triggered by WO310.1016/j.matlet.2016.01.108 ↗
6. Nanoparticles in medicine: therapeutic applications and developments10.1038/sj.clpt.6100400 ↗
7. Communication-Three-dimensional electro- and pH-responsive polypyrrole/alginate hybrid for dual-controlled drug delivery10.1149/2.0291605jes ↗
8. Highly fluorescent and morphology-controllable graphene quantum dots-chitosan hybrid xerogels for in vivo imaging and pH-sensitive drug carrier10.1016/j.msec.2016.05.031 ↗
9. Palygorskite polypyrrole nanocomposite: a new platform for electrically tunable drug delivery10.1016/j.clay.2014.06.020 ↗
10. Facile synthesis of superparamagnetic Fe3O4@Au nanoparticles for photothermal destruction of cancer cells10.1039/c1cc15528h ↗
11. A simple method to construct bifunctional Fe3O4/Au hybrid nanostructures and tune their optical properties in the near-infrared region10.1021/jp9099804 ↗
12. Fe3O4/Au core/shell nanoparticles modified with Ni2+-nitrilotriacetic acid specific to histidine-tagged proteins10.1021/jp910753f ↗
13. Synergistic catalysis of Au@Ag core-shell nanoparticles stabilized on metal-organic framework10.1021/ja1099006 ↗
14. The role of F-centers in catalysis by Au supported on MgO10.1021/ja043652m ↗
15. Enhancement of O2 dissociation on Au (111) by adsorbed oxygen: implications for oxidation catalysis10.1021/ja050144j ↗
16. Novel nanocomposites based on a strawberry-like gold-coated magnetite (Fe@Au) for protein separation in multiple myeloma serum samples10.1007/s12274-014-0599-4 ↗
17. Biological sensing and interface design in gold island film based localized plasmon transducers10.1021/ac8013466 ↗
18. Biological sensing using transmission surface plasmon resonance spectroscopy10.1021/la0489054 ↗
19. Two-photon sensing and imaging of endogenous biological cyanide in plant tissues using graphene quantum dot/gold nanoparticle conjugate10.1021/acsami.5b06352 ↗
20. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods10.1021/ja057254a ↗
21. Oligonucleotides-assembled Au nanorod-assisted cancer photothermal ablation and combination chemotherapy with targeted dual-drug delivery of doxorubicin and cisplatin prodrug10.1021/am5000905 ↗
22. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles10.1016/j.canlet.2005.07.035 ↗
23. PNIPAM gel-coated gold nanorods, for targeted delivery responding to a near-infrared laser10.1021/bc800480k ↗
24. Gold nanoparticles enable selective light-induced contents release from liposomes10.1016/j.jconrel.2007.06.009 ↗
25. Light-responsive polyelectrolyte/gold nanoparticle microcapsules10.1021/jp045070x ↗
26. Temperature-sensitive hydrogels with SiO2-Au nanoshells for controlled drug delivery10.1016/j.jconrel.2007.08.013 ↗
27. Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment10.1002/adma.201104714 ↗
28. Sub-100 nm gold nanoparticle vesicles as a drug delivery carrier enabling rapid drug release upon light irradiation10.1021/am400590m ↗
29. Superparamagnetic high-magnetization microspheres with an Fe3O4@SiO2 core and perpendicularly aligned mesoporous SiO2 shell for removal of microcystins10.1021/ja0777584 ↗
30. pH-sensitive strontium carbonate nanoparticles as new anticancer vehicles for controlled etoposide release
31. Simple and efficient HPLC-UV quantitation of etoposide and its cis-isomer in rat micro-volume plasma and tissue samples: application to pharmacokinetic and biodistribution studies10.1080/10826076.2011.585483 ↗
32. Release of chlorambucil from poly(N-isopropylacrylamide) hydrogels with β-cyclodextrin moieties10.1002/mabi.200400037 ↗
33. Facile one-pot synthesis of Fe3O4@Au composite nanoparticles for dual-mode MR/CT imaging applications10.1021/am4034526 ↗
34. Monodispersed core-shell Fe3O4@Au nanoparticles10.1021/jp0543429 ↗
35. Fe3O4@SiO2 core/shell nanoparticles: the silica coating regulations with a single core for different core sizes and shell thicknesses10.1021/cm302828d ↗
36. Enhanced electrochemical stability of quasi-solid-state electrolyte containing SiO2 nanoparticles for Li-O2 battery applications10.1021/acsami.5b10214 ↗
37. Characterization and application of Fe3O4/SiO2 nanocomposites10.1007/s10971-006-7780-5 ↗
38. Sulfhydryl-modified Fe3O4@SiO2 core/shell nanocomposite: synthesis and toxicity assessment in vitro10.1021/acsami.5b03873 ↗
39. Design of yolk-shell Fe3O4@PMAA composite microspheres for adsorption of metal ions and pH-controlled drug delivery10.1039/C4TA00976B ↗
40. Magnetic adsorbent of Fe3O4@SiO2 core-shell nanoparticles modified with thiol group for chloroauric ion adsorption10.1016/j.apsusc.2016.03.099 ↗
41. Preparation and kinetic study of magnetic Ca/Fe3O4@SiO2 nanocatalysts for biodiesel production10.1016/j.renene.2016.03.086 ↗
42. Study of streptavidin coated onto PAMAM dendrimer modified magnetite nanoparticles10.1016/j.jmmm.2005.01.042 ↗
43. Dendrimer modified magnetite nanoparticles for protein immobilization10.1016/j.jcis.2004.09.073 ↗
44. Novel method to investigate the interaction force between etoposide and APTES-functionalized Fe3O4@nSiO2@mSiO2 nanocarrier for drug loading and release processes10.1021/jp512447s ↗
45. Controlled fabrication of iron oxide/mesoporous silica core-shell nanostructures10.1021/jp4049583 ↗
46. Uniform PEGylated PLGA microcapsules with embedded Fe3O4 nanoparticles for US/MR dual-modality imaging10.1021/acsami.5b06594 ↗
47. Magnetic pickering emulsions stabilized by Fe3O4 nanoparticles10.1021/la1036844 ↗
48. The in vitro sustained release profile and antitumor effect of etoposide-layered double hydroxide nanohybrids10.2147/IJN.S43203 ↗
49. Biocompatible PEG-chitosan@carbon dots hybrid nanogels for two-photon fluorescence imaging, near-infrared light/pH dual-responsive drug carrier, and synergistic therapy10.1002/adfm.201501524 ↗